Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.


Networking Events
  • 10.03.2018
    9th Annual Pulmonary Hypertension Symposium

    Advocate Christ Medical Center Stein Auditorium 93rd Street and Kilbourn Avenue, Oak Lawn, IL
    Advocate Heart Institute at Christ Medical Center presents the 9th Annual Pulmonary Hypertension Symposium, Getting Aggressive in PAH: Setting Goals & Escalating Care. There will be several lectures, case-based discussion, and debate that highlights the evaluation, treatment, and management of all WHO groups ( 1 to 5) of pulmonary hypertension. There will also be a lecture on lung transplant.
  • 10.05.2018
    Innovations in Heart Failure and Pulmonary Hypertension

    Omni Willliam Penn Hotel
    530 William Penn Place
    Pittsburgh, Pennsylvania 15219
    The Cardiovascular Institute is pleased to offer this exciting educational opportunity high-lighting innovations in heart failure and pulmonary hypertension. This course will provide a review of the latest innovations in the management of heart failure including novel medical and surgical treatments, and new insights into the pathogenesis and treatment strategies for pulmonary hypertension patients. It is intended for cardiologists, cardiothoracic surgeons, internists, pulmonologists, critical care specialists, physician assistants, nurse practitioners, nurses, pharmacists and other health care professionals who have direct responsibility for, or interest in, cardiovascular patient care.
    Learn More »
  • 11.02.2018
    10 Annual North Carolina Research Triangle Pulmonary Hypertension Symposium

    Hilton Durham near Duke University
    3800 Hillsborough Rd
    Durham, NC 27708
    United States

    The 10th annual RTP PH symposium will reinforce the current diagnostic and management guidelines of PAH put forth by the 5th and 6th World Symposium on Pulmonary Hypertension, along with the focus on the different subgroups of Pulmonary Hypertension. The diagnosis, management, and treatment for patients with WHO group 2-5 PH will be addressed. Also discussion will focus on medications for Pulmonary Hypertension that are available and the use of these in groups 2 and 3 PH will be addressed. It will provide a plentiful forum for questions and discussion, so that practitioners and health care providers in attendance can have knowledge and reinforcement of appropriate care practices that can be put into practice.
    Learn More »